Evaluation of Clinical Approach and Outcomes Staphylococcus aureus Bacteremia
Open Access
- 11 March 2023
- journal article
- research article
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 5 (1) , 31-39
Abstract
Objective: Despite appropriate treatment and early diagnosis methods, Staphylococcus aureus bacteremia (SAB) is still associated with a high mortality rate. This study aims to evaluate the clinical features and approaches to SAB and to analyze the parameters that may affect 7-day and 30-day mortality. Materials and Methods: Adult patients with SAB data between 2011 and 2018 were evaluated retrospectively. Clinical data, patient demographics, and 7-day and 30-day mortality rates were obtained from their medical records. Results: In total, 144 patients were included in the study; 57.6% (83/144) of patients were men, and the mean age was 65.2±16.5 years. The most common source of infection was the central-line catheter (38.9%), followed by intra-abdominal (21%), respiratory (16.7), infective endocarditis (5.6%), and osteoarticular foci (2.1%). Fifteen percent (15%) of the strains were methicillin resistant. Transthoracic echocardiography (TTE) was performed for 80.6% (116/144) patients. Infectious diseases specialist consultation within 96 hours from blood culture signal was requested in 79.9%. Overall, 7-day mortality was 11.8%, and 30-day mortality was 21.5%. Staying in intensive care units (ICU) increased the risk of 30-day mortality by 1.1 times, and respiratory-focused SAB increased the risk by 4.3 times. Conclusion: SAB is still a big threat. Staphylococcal pneumonia remains a severe infection. Several prognostic factors influence mortality. Identifying the source, ensuring source control, and appropriate initial therapy as soon as possible are critical for reducing mortality and morbidity in SAB. Keywords: Staphylococcus aureus, bacteremia, staphylococcal pneumonia, mortalityKeywords
This publication has 24 references indexed in Scilit:
- Infectious disease consultation for Staphylococcus aureus bacteremia – A systematic review and meta-analysisJournal of Infection, 2016
- Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort StudyClinical Infectious Diseases, 2015
- Clinical Management ofStaphylococcus aureusBacteremiaJAMA, 2014
- Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studiesJournal of Infection, 2014
- Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2013
- Incidence of bloodstream infection: a review of population-based studiesClinical Microbiology and Infection, 2013
- Predictors of Mortality in Staphylococcus aureus BacteremiaClinical Microbiology Reviews, 2012
- A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be doneJournal of Hospital Infection, 2011
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centreClinical Microbiology and Infection, 2006